sorafenib has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Kataoka, M; Ono, T; Sano, M; Satoh, T; Tamura, Y | 1 |
| Balis, FM; Choyke, PL; Dombi, E; Fox, E; Jayaprakash, N; Kim, A; Korf, B; Martin, S; Muradyan, N; Reddy, A; Tepas, K; Turkbey, B; Widemann, BC; Wolters, P | 1 |
1 trial(s) available for sorafenib and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Male; Maximum Tolerated Dose; Neurofibroma, Plexiform; Neurofibromatosis 1; Niacinamide; Phenylurea Compounds; Sorafenib | 2013 |
1 other study(ies) available for sorafenib and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension.
Topics: Adult; Benzenesulfonates; Cardiac Catheterization; Exercise Test; Female; Humans; Hypertension, Pulmonary; Neurofibromatosis 1; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Treatment Outcome; Vascular Resistance | 2012 |